These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23190896)

  • 21. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
    Leyden JJ
    Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease.
    Oshi MA; Naeem M; Bae J; Kim J; Lee J; Hasan N; Kim W; Im E; Jung Y; Yoo JW
    Carbohydr Polym; 2018 Oct; 198():434-442. PubMed ID: 30093020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical application of phenolic compounds suppresses Propionibacterium acnes-induced inflammatory responses in mice with ear edema.
    Dos Santos ZMQ; Dos Santos MQ; Zancanaro V; Bellaver EH; Nardi GM; Gelinski JML; Locatelli C
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):529-540. PubMed ID: 30617549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative activity of benzoyl peroxide and hexachlorophene. In vivo studies against propionibacterium acnes in humans.
    Nacht S; Gans EH; McGinley KJ; Kligman AM
    Arch Dermatol; 1983 Jul; 119(7):577-9. PubMed ID: 6222704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris.
    Mills OH; Kligman AM; Pochi P; Comite H
    Int J Dermatol; 1986 Dec; 25(10):664-7. PubMed ID: 2948929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
    Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
    Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling.
    Raza K; Singh B; Singla S; Wadhwa S; Garg B; Chhibber S; Katare OP
    Mol Pharm; 2013 May; 10(5):1958-63. PubMed ID: 23544848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging topical antimicrobial options for mild-to-moderate acne: a review of the clinical evidence.
    Del Rosso J
    J Drugs Dermatol; 2008 Feb; 7(2 Suppl):s2-7. PubMed ID: 18404864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory and anti-inflammatory effects of the Helicobacter pylori-derived antimicrobial peptide HPA3NT3 against Propionibacterium acnes in the skin.
    Ryu S; Park Y; Kim B; Cho SM; Lee J; Lee HH; Gurley C; Song K; Johnson A; Armstrong CA; Song PI
    Br J Dermatol; 2014 Dec; 171(6):1358-67. PubMed ID: 25313444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery.
    Mukhopadhyay P; Chakraborty S; Bhattacharya S; Mishra R; Kundu PP
    Int J Biol Macromol; 2015 Jan; 72():640-8. PubMed ID: 25239194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bacterial resistance in acne? A meta-analysis of the controversy].
    Alvarez-Sánchez M; Rodríguez-Ayala E; Ponce-Olivera RM; Tirado-Sánchez A; Arellano-Mendoza MI
    Cir Cir; 2016; 84(3):190-5. PubMed ID: 26738649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release Behavior and Antibacterial Activity of Chitosan/Alginate Blends with Aloe vera and Silver Nanoparticles.
    Gómez Chabala LF; Cuartas CEE; López MEL
    Mar Drugs; 2017 Oct; 15(10):. PubMed ID: 29064431
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibitory effect of the antimicrobial peptide BLP-7 against Propionibacterium acnes and its anti-inflammatory effect on acne vulgaris.
    Wu Y; Qiang Y; Cao K; Zhang W; Zhang G
    Toxicon; 2020 Sep; 184():109-115. PubMed ID: 32540219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D
    MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325
    [No Abstract]   [Full Text] [Related]  

  • 36. Exploring Endolysin-Loaded Alginate-Chitosan Nanoparticles as Future Remedy for Staphylococcal Infections.
    Kaur J; Kour A; Panda JJ; Harjai K; Chhibber S
    AAPS PharmSciTech; 2020 Aug; 21(6):233. PubMed ID: 32794119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and characterization of calcium alginate microparticles coated with polycations as protein delivery system.
    Zarate J; Virdis L; Orive G; Igartua M; Hernández RM; Pedraz JL
    J Microencapsul; 2011; 28(7):614-20. PubMed ID: 21740107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzoyl peroxide cleansers for the treatment of acne vulgaris: status report on available data.
    Del Rosso JQ
    Cutis; 2008 Nov; 82(5):336-42. PubMed ID: 19090337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.